Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 946 AL 960

Physical exercise in Parkinson disease: moving toward more robust evidence?

Rascol O.

Mov Disord. 2013 Aug;28(9):1173-5. doi: 10.1002/mds.25453. Epub 2013 Apr 15.

Transcortical motor aphasia and unilateral parkinsonism in a case of hyperostosis frontalis

Brodoehl S, Klingner C, Mentzel H, Bär KJ.

Neurology. 2013 Apr 16;80(16):1536-7. doi: 10.1212/WNL.0b013e31828cf8b8.

Roles and therapeutic potential of metallothioneins in neurodegenerative diseases

Hozumi I.

Curr Pharm Biotechnol. 2013;14(4):408-13. doi: 10.2174/1389201011314040004.

Reaching to proprioceptively defined targets in Parkinson's disease: effects of deep brain stimulation therapy

Lee D, Henriques DY, Snider J, Song D, Poizner H.

Neuroscience. 2013 Aug 6;244:99-112. doi: 10.1016/j.neuroscience.2013.04.009. Epub 2013 Apr 13.

Application of two-phase hollow fiber liquid phase microextraction coupled with high-performance liquid chromatography for the study of the echinacoside pharmacokinetics in Parkinson's disease rat plasma

Zhou J, Zeng P, Sun JB, Wang FQ, Zhang Q.

J Pharm Biomed Anal. 2013 Jul-Aug;81-82:27-33. doi: 10.1016/j.jpba.2013.03.020. Epub 2013 Apr 3.

Neuropsychological deficits associated with destruction of the right nigrostriatal pathway

Sáez-Zea C, Escamilla-Sevilla F, Martínez-Simón J, Arnedo M, Mínguez-Castellanos A.

J Int Neuropsychol Soc. 2013 Jul;19(6):729-34. doi: 10.1017/S1355617713000416. Epub 2013 Apr 17.

Disease progression and neuroscience

Holford N.

J Pharmacokinet Pharmacodyn. 2013 Jun;40(3):369-76. doi: 10.1007/s10928-013-9316-2. Epub 2013 Apr 17.

Post-dengue parkinsonism

Azmin S, Sahathevan R, Suehazlyn Z, Law ZK, Rabani R, Nafisah WY, Tan HJ, Norlinah MI.

BMC Infect Dis. 2013 Apr 18;13:179. doi: 10.1186/1471-2334-13-179.

Surface electrical stimulation in dysphagic Parkinson patients: a randomized clinical trial

Baijens LW, Speyer R, Passos VL, Pilz W, van der Kruis J, Haarmans S, Desjardins-Rombouts C.

Laryngoscope. 2013 Nov;123(11):E38-44. doi: 10.1002/lary.24119. Epub 2013 Apr 17.

Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care

Antonini A, Odin P, Opiano L, Tomantschger V, Pacchetti C, Pickut B, Gasser UE, Calandrella D, Mancini F, Zibetti M, Minafra B, Bertaina I, De Deyn P, Cras C, Wolf E, Spielberger S, Poewe W.

J Neural Transm (Vienna). 2013 Nov;120(11):1553-8. doi: 10.1007/s00702-013-1026-9. Epub 2013 Apr 18.

Ambulation and Parkinson disease

Amano S, Roemmich RT, Skinner JW, Hass CJ.

Phys Med Rehabil Clin N Am. 2013 May;24(2):371-92. doi: 10.1016/j.pmr.2012.11.003. Epub 2013 Jan 22.

Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?

Chinta SJ, Lieu CA, Demaria M, Laberge RM, Campisi J, Andersen JK.

J Intern Med. 2013 May;273(5):429-36. doi: 10.1111/joim.12029.

The role of dopamine receptors in the neurotoxicity of methamphetamine

Ares-Santos S, Granado N, Moratalla R.

J Intern Med. 2013 May;273(5):437-53. doi: 10.1111/joim.12049.

Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system

McCarthy CA, Widdop RE, Deliyanti D, Wilkinson-Berka JL.

Clin Exp Pharmacol Physiol. 2013 Aug;40(8):571-9. doi: 10.1111/1440-1681.12099.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias